BACKGROUND: The prevalence of Chagas' disease is decreasing in Brazil. Due to cohort effect, the disease might remain a public health problem for some time among older individuals. The present burden of Trypanosoma cruzi infection for the elderly living in areas where the transmission has been interrupted has not been studied. METHODS: The prevalence of T. cruzi infection and its association with indicators of health status and health services use were assessed among the elderly living in one of the oldest endemic areas in Brazil (Bambuí, MG). Seropositivity was determined by blood tests (IHA and ELISA) performed in 85.6% of all residents aged 60+ (1496/1742) and in 83.1% of sampled residents aged 5-59 years (1212/1458). RESULTS: Seropositivity showed a cohort effect, with no cases below 20 years and high prevalence among those aged 60+ years (37.7%). After adjustment for confounders, seropositivity was associated with self-rated health reasonable (OR = 1.43; 95% CI : 1.03-1.98) and bad/very bad (OR = 1.89; 95% CI : 1.30-2.75), staying in bed in past 2 weeks (OR = 1.88; 95% CI : 1.21-2.92), hospitalization in past 12 months (OR = 1.41; 95% CI : 1.05-1.89) and use of 5+ prescribed medications in past 3 months (OR = 1.75; 95% CI : 1.15-2.59). IMPLICATIONS: Our results are an example of how survival of individuals with past exposure to infectious disease may lead to a different picture of ageing in the developing world. Policy makers need to consider the extra burden imposed by increasing rates of non-infectious disease among the elderly (as observed in Brazil) including the consequences of T. cruzi infection in areas where the infection was widespread in the past.
BACKGROUND: The prevalence of Chagas' disease is decreasing in Brazil. Due to cohort effect, the disease might remain a public health problem for some time among older individuals. The present burden of Trypanosoma cruzi infection for the elderly living in areas where the transmission has been interrupted has not been studied. METHODS: The prevalence of T. cruzi infection and its association with indicators of health status and health services use were assessed among the elderly living in one of the oldest endemic areas in Brazil (Bambuí, MG). Seropositivity was determined by blood tests (IHA and ELISA) performed in 85.6% of all residents aged 60+ (1496/1742) and in 83.1% of sampled residents aged 5-59 years (1212/1458). RESULTS: Seropositivity showed a cohort effect, with no cases below 20 years and high prevalence among those aged 60+ years (37.7%). After adjustment for confounders, seropositivity was associated with self-rated health reasonable (OR = 1.43; 95% CI : 1.03-1.98) and bad/very bad (OR = 1.89; 95% CI : 1.30-2.75), staying in bed in past 2 weeks (OR = 1.88; 95% CI : 1.21-2.92), hospitalization in past 12 months (OR = 1.41; 95% CI : 1.05-1.89) and use of 5+ prescribed medications in past 3 months (OR = 1.75; 95% CI : 1.15-2.59). IMPLICATIONS: Our results are an example of how survival of individuals with past exposure to infectious disease may lead to a different picture of ageing in the developing world. Policy makers need to consider the extra burden imposed by increasing rates of non-infectious disease among the elderly (as observed in Brazil) including the consequences of T. cruzi infection in areas where the infection was widespread in the past.
Authors: Breno S Diniz; Maria Fernanda Lima-Costa; Sérgio Viana Peixoto; Joselia O A Firmo; Karen C L Torres; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; James Grady; George A Kuchel; Erico Castro-Costa Journal: Am J Geriatr Psychiatry Date: 2022-02-03 Impact factor: 7.996
Authors: M Fernanda Lima-Costa; Erico Castro-Costa; Elizabeth Uchôa; Joselia Firmo; Antonio Luiz P Ribeiro; Cleusa P Ferri; Martin Prince Journal: Neuroepidemiology Date: 2008-12-16 Impact factor: 3.282
Authors: Maria Carmo P Nunes; Lewis F Buss; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Jose Luiz P Silva; Larissa Natany A Martins; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Bruno Oliveira de Figueiredo Brito; Ariela Mota Ferreira; Lea Campos Oliveira; Ana Luiza Bierrenbach; Fabio Fernandes; Michael P Busch; Viviane Tiemi Hotta; Luiz Mario Baptista Martinelli; Maria Carolina F Almeida Soeiro; Adriana Brentegani; Vera M C Salemi; Marcia M Menezes Journal: Circulation Date: 2021-09-27 Impact factor: 29.690
Authors: José Alberto Martins da Matta; Roque Aras; Cristiano Ricardo Bastos de Macedo; Cristiano Gonçalves da Cruz; Eduardo Martins Netto Journal: PLoS One Date: 2012-04-16 Impact factor: 3.240
Authors: Laíse dos Santos Pereira; Erlane Chaves Freitas; Arduína Sofia Ortet de Barros Vasconcelos Fidalgo; Mônica Coelho Andrade; Darlan da Silva Cândido; José Damião da Silva Filho; Vladimir Michailowsky; Maria de Fátima Oliveira; José Ajax Nogueira Queiroz Journal: Rev Inst Med Trop Sao Paulo Date: 2015 Mar-Apr Impact factor: 1.846
Authors: Michael Z Levy; Vivian Kawai; Natalie M Bowman; Lance A Waller; Lilia Cabrera; Viviana V Pinedo-Cancino; Amy E Seitz; Frank J Steurer; Juan G Cornejo del Carpio; Eleazar Cordova-Benzaquen; James H Maguire; Robert H Gilman; Caryn Bern Journal: PLoS Negl Trop Dis Date: 2007-12-26
Authors: Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa Journal: J Am Heart Assoc Date: 2014-02-07 Impact factor: 5.501
Authors: Alline M Beleigoli; Eric Boersma; Maria de Fátima H Diniz; Pedro G Vidigal; Maria Fernanda Lima-Costa; Antonio L Ribeiro Journal: PLoS One Date: 2013-09-25 Impact factor: 3.240